HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The predictive value for pulmonary infection by area over the neutrophil curve (D-index) in patients who underwent reduced intensity hematopoietic stem cell transplantation.

Abstract
We evaluated the predictive value of the D-index for pulmonary infection in the early phase of reduced intensity stem cell transplantation (RIST). Out of 68 patients, ten patients developed a pulmonary infection within 100 days after RIST. Both the D-index and the cD-index were higher in the patients with pulmonary infection than in the control group (P = 0.009, P = 0.042, respectively). The best sensitivity and specificity, calculated with receiver operating characteristic curves, showed that the D-index was superior to the duration of neutropenia in predicting pulmonary infection. We also evaluated the utility of a cumulative D-index until 21 days after RIST (D21-index). The D21-index was higher in the patients with pulmonary infection (P = 0.047). The cutoff value of the D21-index was lower than that of the D-index (8650 vs. 11000) with comparable sensitivity and specificity. Our results demonstrate that the D21-index, as well as the D-index, are useful tools for the prediction of pulmonary infection in RIST.
AuthorsJun Aoki, Masaharu Tsubokura, Kazuhiko Kakihana, Gaku Oshikawa, Takeshi Kobayashi, Noriko Doki, Hisashi Sakamaki, Kazuteru Ohashi
JournalPathology oncology research : POR (Pathol Oncol Res) Vol. 20 Issue 4 Pg. 879-83 (Oct 2014) ISSN: 1532-2807 [Electronic] Switzerland
PMID24705712 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Hematologic Neoplasms (complications, therapy)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Lung Diseases, Fungal (blood, etiology, pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Neutrophils (pathology)
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Transplantation Conditioning (adverse effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: